Neuroticism and Somatic Symptoms: Symptom Reporting, Distress, and Health Context
Author: Ukrainian Psychological Hub · Published: September 30, 2026 · Editorial Policy
Neuroticism is reliably associated with reporting more somatic symptoms—physical experiences such as pain, fatigue, dizziness, gastrointestinal discomfort, palpitations, breathlessness, or other bodily complaints—but the meaning of that association requires care. Neuroticism is a dimensional personality trait, not a medical diagnosis and not a test of whether a symptom is “real.” Research suggests that higher neuroticism can be related to greater attention to bodily sensations, stronger negative emotional responses to symptoms, worry and rumination, current distress, and—in some studies—later physical-health or functional-somatic outcomes. None of those pathways justifies dismissing physical symptoms as psychological.
The central distinction is between a person’s tendency to experience and report negative affect and the cause of a particular bodily symptom. A symptom can reflect a diagnosed medical condition, a functional somatic disorder, medication effects, sleep loss, stress-related physiological processes, anxiety, depression, several factors at once, or a cause that has not yet been established. Personality research answers a population-level question about associations and risk; it does not replace medical assessment.
Neuroticism and somatic symptoms: the short answer
Across several decades of research, higher neuroticism has been associated with a greater number or burden of self-reported physical symptoms. In a population cohort of 6,894 adults, Rosmalen and colleagues found that neuroticism, measured with the Eysenck Personality Questionnaire Revised Short Scale–Neuroticism (EPQ-RSS-N), was associated with the total number of 22 common somatic symptoms even after adjustment for age, sex, and psychological distress. The association was stronger for symptoms categorized by the investigators as psychosomatic than for infectious or allergic symptoms: Rosmalen et al. (2007), PubMed.
A recent systematic review and meta-analysis provides a more contemporary view for functional somatic disorders (FSD). Across 52 included studies, Lamm and colleagues found that FSD groups scored higher on neuroticism than healthy or unspecified controls, with a pooled standardized difference of Hedges’ g = 0.72 across 46 comparisons. The difference was smaller when FSD groups were compared with somatic-control groups (g = 0.26 across nine comparisons), and the literature showed substantial heterogeneity. Most included comparisons were not designed to establish one-way causation: Lamm et al. (2025), PubMed.
Longitudinal evidence also matters. In the DanFunD population study, 4,288 adults were followed for about five years. Neuroticism measured with a short-form NEO Personality Inventory predicted incident functional somatic disorder and chronic fatigue in adjusted observational models. Perceived stress and adverse life events also contributed, underscoring that neuroticism is one part of a multivariable risk picture rather than a stand-alone cause or diagnostic marker: Petersen et al. (2024), PubMed.
What “somatic symptoms” means here
Somatic symptoms are bodily symptoms. The term describes the domain of experience, not its cause. Headache, abdominal discomfort, fatigue, back pain, chest sensations, shortness of breath, nausea, weakness, and dizziness are examples of somatic symptoms because they are experienced in the body. The same symptom can occur in a medical disease, during acute stress, in a functional disorder, as a medication side effect, alongside anxiety or depression, or without a cause that is immediately identifiable.
Research studies operationalize somatic symptoms in different ways. Some count common complaints; some use validated symptom-burden questionnaires such as the Somatic Symptom Scale–8 (SSS-8); some examine physician-diagnosed conditions; some study functional somatic disorders; and some use retrospective reports of illness. These outcomes cannot be treated as interchangeable. The SSS-8, for example, is a patient-reported measure of eight common somatic symptoms and was validated in a representative German sample; it measures symptom burden, not neuroticism and not a psychiatric diagnosis: Gierk et al. (2014), PubMed.
What neuroticism means in this research
In modern personality science, neuroticism describes relatively stable individual differences in the tendency to experience negative emotions and distress, including worry, fear, sadness, irritability, self-consciousness, and vulnerability under stress. It is continuous: people vary along a dimension rather than falling into a universal “neurotic” versus “non-neurotic” category. For the core Big Five construct, see Neuroticism: What It Is in the Big Five Personality Model.
Terminology depends on the instrument. NEO instruments use the domain label Neuroticism. Eysenck inventories also include a Neuroticism scale, but the model, items, scoring, and norms differ from NEO instruments. The BFI-2 labels the corresponding Big Five domain Negative Emotionality and represents it through Anxiety, Depression, and Emotional Volatility facets. Soto and John’s BFI-2 development paper documents this structure: Soto & John (2017), PubMed. A raw score or percentile from one instrument should not be translated into another instrument’s score without a validated conversion.
Neuroticism is related to negative affect, but the terms are not identical. Negative affect can refer to a current emotional state or to a broader dispositional tendency, depending on the measure and research tradition. Trait anxiety is narrower than broad neuroticism. Anxiety symptoms and depressive symptoms are clinical phenomena that can fluctuate over time. Somatic symptom burden is yet another construct. A study that measures one of these variables cannot automatically be read as if it measured all the others.
Why neuroticism and bodily symptoms can be associated
There is no single accepted mechanism that explains the neuroticism–somatic symptom association. Several pathways can operate together, and their relative importance can differ across people, symptoms, time periods, and medical contexts. The strongest interpretation is therefore a multi-pathway model rather than a claim that personality simply generates physical complaints.
Attention to bodily sensations
People differ in how readily bodily changes enter attention. A person who more often monitors internal sensations may notice transient discomfort, heartbeat changes, tension, gastrointestinal sensations, or fatigue that another person would not encode as salient. Neuroticism is associated with threat sensitivity and negative emotional reactivity, so bodily sensations may be more likely to capture attention when they are ambiguous or uncomfortable. Attention can increase the amount of symptom information available for later reporting without implying that the sensations were fabricated.
Interpretation and threat appraisal
The same bodily sensation can be interpreted as harmless, inconvenient, uncertain, or threatening. Higher neuroticism is associated with a greater tendency toward negative appraisal across many domains. When applied to health, this can increase distress about bodily sensations and make them more memorable or behaviorally important. This is closely related to health anxiety, but the two constructs remain distinct. The dedicated relationship is covered in Neuroticism and Health Anxiety: Bodily Threat, Worry, and Illness Concerns.
Current negative affect and symptom experience
Trait and state effects can be separated only imperfectly in self-report research. Event-sampling work has shown that unpleasant affective states can be strongly related to concurrent physical symptom experience even when broad trait neuroticism is not the strongest moment-to-moment predictor. Brown and Moskowitz found substantial individual variability in the direction and strength of these links: Brown & Moskowitz (1997), PubMed. This is one reason a person’s current anxiety, depression, sleep, pain, stress, and recent illness matter when interpreting symptom reports.
Memory and retrospective reporting
Reporting symptoms over the past day, week, month, or year requires memory and summary judgments. The classic symptom-perception literature proposed that negative affectivity can influence how people recall and aggregate bodily experiences. Later work refined that idea by showing that anxiety and depressive affect may relate differently to concurrent versus retrospective reports. Howren and Suls tested these distinctions across three studies: Howren & Suls (2011), PubMed. The implication is methodological as well as clinical: a retrospective symptom count is not identical to a momentary diary of bodily experience.
Worry and rumination
Worry and rumination are plausible cognitive pathways because they prolong attention to threat, distress, and unresolved concerns. In a convenience sample of 170 adults, Denovan, Dagnall, and Lofthouse used the EPQ-Revised Short Form, Penn State Worry Questionnaire, Ruminative Response Scale, and SSS-8. Their cross-sectional structural model suggested that rumination statistically mediated the association between neuroticism and somatic complaints. Because the design was cross-sectional and the sample was small, this finding supports a hypothesis rather than proving a causal chain: Denovan et al. (2019), Cambridge Core.
Stress exposure, reactivity, and recovery
Neuroticism is also associated with perceived stress and emotional reactivity. This can matter for physical symptoms through sleep disruption, muscle tension, autonomic arousal, health behavior, pain amplification, and other stress-related processes. These are plausible biopsychosocial pathways, but they should not be compressed into the statement that “stress causes the symptom.” For any individual symptom, the causal question remains specific to the person, timing, medical history, and condition.
Symptom reporting is not the same as symptom invention
One of the most important errors in this literature is to turn a statistical association with symptom reporting into a claim that people high in neuroticism imagine symptoms. A symptom report is a person’s report of an experienced bodily phenomenon. The experience can be intense and disabling whether or not a single structural lesion, laboratory abnormality, or disease mechanism has been identified. Reporting processes can affect how symptoms are noticed, remembered, described, and rated; those processes do not make the experience fictitious.
The American Psychiatric Association explicitly makes the same distinction in the context of somatic symptom disorder: symptoms may or may not be associated with a diagnosed medical condition, and the person is not faking illness. Diagnosis is not made merely because a medical explanation has not been identified. Instead, somatic symptom disorder requires distressing or disruptive physical symptoms together with excessive symptom-related thoughts, feelings, or behaviors: American Psychiatric Association: What Is Somatic Symptom Disorder?.
This distinction protects against two opposite mistakes. One is medical reductionism that ignores how attention, emotion, stress, cognition, and behavior can shape symptom burden. The other is psychologization that attributes a physical complaint to personality before appropriate medical evaluation. Good assessment allows biological, psychological, and social contributors to be investigated in parallel.
The symptom-perception hypothesis and its limits
Classic work by Costa and McCrae found that neuroticism was strongly related to physical complaint reporting and proposed that selective perception or reporting could contribute to the association. Their Baltimore Longitudinal Study of Aging analysis did not find the same pattern for mortality in the data then available: Costa & McCrae (1987), PubMed. Watson and Pennebaker likewise argued that self-reported health complaints and self-reported stress share variance with negative affectivity, which can inflate correlations between them: Watson & Pennebaker (1989), PubMed.
Those classic findings remain important for measurement, but they are not evidence that the entire neuroticism–health relationship is a reporting artifact. Later research has linked personality to outcomes beyond contemporaneous complaint questionnaires. A metasynthesis of 36 meta-analyses covering more than 500,000 participants found broad associations between Big Five personality and health, while also showing that associations were larger for mental-health than physical-health outcomes and varied by source and measurement method: Strickhouser, Zell, & Krizan (2017), PubMed.
Biomarker research provides another counterweight to a pure-reporting explanation. A 2023 systematic review and meta-analysis of 11 studies found a small positive association between neuroticism and allostatic load, an index built from multiple physiological biomarkers: Yoneda et al. (2023), PubMed. The effect was small and group-level. It does not show that a particular person’s symptoms are caused by neuroticism, but it illustrates why subjective reporting and objective physiology should be studied together rather than treated as mutually exclusive explanations.
Cross-sectional evidence versus longitudinal evidence
Cross-sectional studies ask whether neuroticism and symptoms are associated at the same time. They can establish covariance, but they cannot determine temporal direction. Higher neuroticism could precede symptom burden; current illness or distress could influence personality self-report; shared causes could affect both; or all of these processes could coexist.
Prospective data strengthen temporal inference without automatically establishing causality. Neeleman, Bijl, and Ormel followed adults for three years and found reciprocal prospective associations: baseline neuroticism was associated with later somatic and psychiatric morbidity after adjustment for baseline morbidity, while baseline morbidity was also associated with higher later neuroticism: Neeleman, Bijl, & Ormel (2004), PubMed. That pattern is difficult to reconcile with a one-directional story in which personality alone produces later symptoms.
Intensive longitudinal data make the picture still more person-specific. Kelly, Weigard, and Beltz collected 75 daily observations from 119 adults. Their individual-level networks were heterogeneous, and physical symptoms more often predicted next-day indicators of neuroticism than the reverse: Kelly et al. (2020), PubMed. This does not overturn the broader trait literature; it shows that between-person associations and within-person day-to-day dynamics answer different questions.
Functional somatic disorders are a related but narrower research context
Functional somatic disorder is used in parts of the research literature as an umbrella framework for persistent, troublesome physical symptoms and related syndromes. The exact taxonomy is still an area of active clinical and research discussion, so FSD should not be used as a synonym for “somatic symptoms” in general. Most people who report headaches, fatigue, abdominal discomfort, or other bodily symptoms are not thereby classified as having an FSD.
The 2025 meta-analysis by Lamm and colleagues is important precisely because it used explicit FSD case definitions and comparison groups. The larger neuroticism difference versus healthy or unspecified controls than versus somatic controls suggests that the choice of comparison group substantially changes the estimated association. That is a useful caution against headlines that imply a single universal neuroticism profile for people with physical symptoms: Lamm et al. (2025), PubMed.
The DanFunD prospective study adds temporal information, but it remains observational. Neuroticism predicted some incident FSD outcomes over five years, while perceived stress and adverse life events also predicted outcomes. Observational prediction is stronger evidence than a one-time correlation, yet it still does not identify a single causal mechanism or support individual deterministic prediction: Petersen et al. (2024), PubMed.
Somatic symptom disorder is not high neuroticism
Somatic symptom disorder (SSD) is a clinical diagnosis. Neuroticism is a personality dimension. A person can score high on neuroticism without SSD, and a person can meet criteria for SSD without an extreme neuroticism score. A personality inventory does not establish the diagnostic criteria for SSD.
The DSM framework also does not define SSD as “physical symptoms with no medical explanation.” The American Psychiatric Association states that symptoms may or may not accompany a diagnosed medical condition and that an SSD diagnosis is not made simply because a medical cause cannot be demonstrated. The diagnostic focus includes the person’s excessive symptom-related thoughts, feelings, or behaviors and the resulting distress or functional disruption: American Psychiatric Association.
That difference matters for both clinical safety and search intent. This article explains a trait–symptom association. It does not provide a diagnostic guide for SSD, and it does not use neuroticism as a substitute for a medical or psychiatric assessment.
Where negative affect, anxiety, and depression fit
Neuroticism overlaps conceptually and statistically with a broad tendency toward negative emotional experience. Anxiety and depression can also increase symptom awareness, physiological arousal, pain, fatigue, sleep problems, gastrointestinal distress, and retrospective symptom reporting. If a study measures current anxiety or depressive symptoms, those variables can partly account for—or sometimes complicate—the observed neuroticism association.
This is one reason research designs differ in whether they adjust for current distress. Rosmalen and colleagues included GHQ-12 psychological distress and still found an independent association between EPQ-RSS-N neuroticism and common somatic symptom counts: Rosmalen et al. (2007), PubMed. Yet event-sampling research found that momentary unpleasant affect could be more closely related to concurrent symptoms than trait neuroticism: Brown & Moskowitz (1997), PubMed. Both findings can be true because trait and state measures operate at different timescales.
For the broader clinical-risk architecture, see Neuroticism and Mental Health: Why the Trait Is a Transdiagnostic Risk Factor. For the narrower neuroticism–anxiety relationship, see Neuroticism and Anxiety: What Research Shows.
Measurement changes the meaning of the result
A statement such as “high neuroticism predicts somatic symptoms” is incomplete unless the neuroticism instrument, symptom instrument, scoring method, population, and design are known. In the 2007 population cohort, neuroticism was measured with EPQ-RSS-N. In DanFunD, it was measured with a short-form NEO Personality Inventory. In Denovan and colleagues’ study, neuroticism came from the Eysenck Personality Questionnaire Revised–Short Form while somatic symptom burden was measured with the SSS-8. These are related operationalizations, not interchangeable numerical scales.
The same caution applies to symptom burden. The SSS-8 has its own scoring and reference framework. A score on the SSS-8 is not a neuroticism score, and a “high” SSS-8 category is not a diagnosis of somatic symptom disorder. Gierk and colleagues developed severity categories for the SSS-8 within its validation framework, but those categories should be interpreted as symptom-burden categories for that instrument: Gierk et al. (2014), PubMed.
Similarly, a high NEO Neuroticism score, high EPQ Neuroticism score, or high BFI-2 Negative Emotionality score does not have a universal medical meaning. Raw scores depend on the questionnaire. Percentiles depend on the normative sample and population. Cutoffs created for one study should not be carried into another instrument or clinical setting unless that use has been validated.
Trait neuroticism can be relatively stable while symptoms fluctuate
Personality traits are relatively stable, not fixed. Physical symptoms and psychiatric states can change much more quickly. This difference in timescale is clinically important because someone can have a stable tendency toward higher negative emotionality while symptom burden rises and falls with infection, sleep, stress, hormonal changes, medication, injury, chronic illness, life events, or treatment.
In a six-month study of 318 primary-care patients presenting with medically unexplained symptoms, De Gucht found that neuroticism and alexithymia were substantially stable while negative affect, positive affect, anxiety, and depression changed over time: De Gucht (2003), PubMed. The historical diagnostic terminology in that study reflects its publication period, but the longitudinal distinction between trait measures and changing affective states remains useful.
The reverse influence is also possible: persistent illness and distress can alter how people describe themselves. Prospective research on neuroticism and common mental disorders has long distinguished vulnerability, shared causes, spectrum overlap, state effects, and scar effects rather than assuming a single direction. Ormel and colleagues review these competing models: Ormel et al. (2013), PubMed.
Does neuroticism cause somatic symptoms?
Current evidence does not justify a universal causal statement. Cross-sectional associations are robust in many samples, longitudinal studies show that neuroticism can precede some later health or functional-somatic outcomes, and plausible psychological and physiological mechanisms exist. At the same time, reverse effects, shared causes, current mood, measurement overlap, medical illness, stress exposure, health behavior, and reporting processes can all contribute.
A stronger causal claim would require converging evidence that establishes temporal ordering, rules out major confounding and reverse causation, identifies a plausible mechanism, and replicates across methods and populations. The literature is not at the point where a neuroticism score can tell a clinician what caused a particular person’s pain, fatigue, gastrointestinal symptoms, dizziness, or cardiopulmonary sensations.
The most defensible formulation is therefore probabilistic: higher neuroticism is associated with greater average somatic symptom reporting and, in some longitudinal studies, greater risk of later functional-somatic or physical-health problems. The association is heterogeneous and does not establish individual causation.
Are the symptoms “all in the mind”?
No. “Mind versus body” is a poor model for interpreting this research. Attention, emotion, autonomic arousal, pain processing, sleep, inflammation, endocrine activity, behavior, medication, illness, and social context can interact. Psychological processes are embodied processes, and physical illness can change mood and cognition. A symptom can be affected by stress or attention while also having a medical component.
The presence of neuroticism or anxiety should therefore never be used as a shortcut to stop medical reasoning. The APA’s guidance on somatic symptom disorder is explicit that people can have SSD alongside medical disease and that failure to demonstrate a medical cause is not sufficient for a psychiatric diagnosis: American Psychiatric Association.
What objective health evidence adds
The reporting-bias hypothesis predicts that neuroticism should relate more strongly to subjective complaints than to objective disease indicators. Some evidence supports that pattern. The 2017 metasynthesis by Strickhouser and colleagues found that personality–health associations varied by outcome type and measurement source, while classic studies showed especially strong links with self-reported complaints: Strickhouser et al. (2017), PubMed.
Other evidence shows that the physical-health relationship cannot be reduced to reporting alone. The allostatic-load meta-analysis found a small association between neuroticism and multisystem biomarker burden: Yoneda et al. (2023), PubMed. Lahey’s review also summarizes prospective associations of neuroticism with diverse health outcomes and health-service use while emphasizing conceptual and measurement issues: Lahey (2009), PMC.
The magnitude and mechanism depend on the health outcome. A subjective pain rating, a symptom diary, physician-confirmed diagnosis, biomarker composite, hospitalization, and mortality are fundamentally different endpoints. Good evidence synthesis does not treat them as if they measure a single thing called “health.”
Clinical implications without psychologizing the patient
For clinicians and patients, the useful question is not whether neuroticism makes symptoms genuine or false. The useful question is which processes are contributing to distress, disability, symptom persistence, health behavior, and care needs. A broad assessment can include medical evaluation, symptom timing, medications, sleep, activity, stress, anxiety, depression, trauma history when relevant, health anxiety, coping, and the person’s own interpretation of symptoms.
Personality can add context. Someone high in neuroticism may be more vulnerable to distress when symptoms are ambiguous, may monitor changes more closely, or may find uncertainty harder to tolerate. That information can guide communication and coping support. It should not be used to discount laboratory findings, physical examination, changing symptoms, or the need for follow-up.
A high trait score alone is not an indication for medication and does not define a disease that must be “cured.” Treatment decisions target diagnosable conditions, clinically significant symptoms, impairment, or modifiable processes such as anxiety, insomnia, depression, avoidance, catastrophic interpretation, or maladaptive coping when those are actually present.
When physical symptoms deserve medical evaluation
New, severe, persistent, rapidly changing, or otherwise concerning physical symptoms deserve appropriate medical assessment regardless of personality. A known history of anxiety, depression, functional symptoms, or high neuroticism does not make future symptoms medically irrelevant. The clinical task is to evaluate the symptom in context rather than infer its cause from a trait label.
When tests do not reveal a clear cause, continued care can still focus on symptom burden, functioning, appropriate follow-up, and evidence-based management. “No cause found yet” and “the symptom is imaginary” are not equivalent statements. Likewise, receiving a psychological formulation for part of a symptom pattern does not negate biological contributors.
How to interpret a neuroticism score if you have physical symptoms
First identify the instrument. A NEO PI-R or NEO-family score, EPQ Neuroticism score, BFI-2 Negative Emotionality score, or IPIP-based score has meaning only within its own scoring system. Check whether the result is a raw score, standardized score, percentile, or norm-referenced category and which population provided the norms.
Then separate trait interpretation from symptom interpretation. The personality score describes a broad tendency in emotional experience and reactivity. It does not identify the cause of fatigue, pain, dizziness, gastrointestinal symptoms, palpitations, or any other physical complaint. It also does not diagnose anxiety, depression, somatic symptom disorder, functional somatic disorder, or another clinical condition.
Finally, interpret the score alongside the person’s current state. Acute illness, major stress, depression, anxiety, sleep deprivation, and other states can influence responses to self-report questionnaires. Repeated assessment and clinical context can be more informative than treating a single score as a permanent biological fact.
What the evidence supports—and what it does not
The evidence supports an association between higher neuroticism and greater average somatic symptom reporting across many studies. It supports meaningful roles for current distress, symptom attention, appraisal, memory, worry, rumination, stress, and other processes. It also supports prospective links between neuroticism and some later somatic or functional-somatic outcomes, although the strength and meaning of those links depend on design and outcome.
The evidence does not support diagnosing a physical or psychiatric disorder from a neuroticism score. It does not support assuming that unexplained symptoms are invented. It does not support a universal claim that neuroticism causes bodily symptoms. It does not support converting scores across NEO, BFI-2, Eysenck, IPIP, or other instruments as though they share a universal cutoff. And it does not support using personality as a reason to bypass appropriate medical evaluation.
Frequently asked questions
Is neuroticism associated with more physical symptoms?
Yes, at the group level. Large cohort studies and other research have repeatedly found that higher neuroticism is associated with greater self-reported somatic symptom burden. The association varies by outcome, instrument, population, and study design and does not determine what any individual symptom means.
Does high neuroticism mean my symptoms are psychological?
No. Neuroticism is a personality trait, not an etiological diagnosis. Physical symptoms can have medical, functional, psychological, behavioral, environmental, or mixed contributors. A personality score cannot identify the cause.
Does neuroticism cause somatic symptom disorder?
Research supports associations between neuroticism and somatic symptom burden, but a simple one-way causal claim is not established. Somatic symptom disorder has its own clinical criteria and cannot be diagnosed from neuroticism.
Are somatic symptoms imaginary if tests are normal?
No. A symptom can be genuine and distressing even when routine testing has not identified a structural explanation. The absence of a demonstrated medical cause is not itself evidence of fabrication and is not sufficient for a psychiatric diagnosis.
Is neuroticism the same as health anxiety?
No. Neuroticism is a broad personality dimension; health anxiety concerns illness-related threat, worry, interpretation, and behavior. They can be associated, but neither is reducible to the other. See Neuroticism and Health Anxiety: Bodily Threat, Worry, and Illness Concerns.
Can anxiety or depression increase symptom reporting?
Yes. Current anxiety and depressive affect can influence bodily arousal, attention, pain, fatigue, memory, and symptom reporting. This is one reason studies should distinguish stable trait neuroticism from current emotional state and psychiatric symptoms.
Which neuroticism test is used in somatic-symptom research?
There is no single universal test. Studies have used Eysenck Neuroticism scales, NEO instruments, and other Big Five measures. The BFI-2 uses the label Negative Emotionality. Findings should be interpreted within the instrument actually used.
Can a high neuroticism score diagnose a functional somatic disorder?
No. A trait score can be a research risk marker or correlate, but FSD case definitions depend on symptom patterns and the specific clinical or research framework. Neuroticism is not a diagnostic test.
Can physical illness affect neuroticism scores?
Yes, current illness and distress can influence self-report, and longitudinal research supports reciprocal relationships between morbidity and later neuroticism. Traits are relatively stable but not immune to state effects or life experience.
Is the neuroticism–health link only reporting bias?
No. Reporting and perception processes matter, especially for self-reported symptom outcomes, but prospective studies and biomarker research indicate that the broader personality–health relationship extends beyond a simple reporting artifact. The size and mechanism depend on the outcome.
Should high neuroticism itself be treated?
A high trait score is not a disease. Clinical care addresses distress, impairment, specific disorders, health behaviors, coping processes, or other problems that are actually present. Personality may change over time, but symptom improvement and trait change are not the same outcome.
What should I do if I have persistent physical symptoms and high neuroticism?
Use the personality result as context, not as an explanation. Seek appropriate medical assessment for persistent or concerning symptoms, and address anxiety, stress, sleep, depression, avoidance, or health-related worry when those are contributing to distress. Both medical and psychological contributors can be relevant at the same time.
Related Articles
References
American Psychiatric Association. (n.d.). What is somatic symptom disorder? https://www.psychiatry.org/patients-families/somatic-symptom-disorder/what-is-somatic-symptom-disorder
Brown, K. W., & Moskowitz, D. S. (1997). Does unhappiness make you sick? The role of affect and neuroticism in the experience of common physical symptoms. Journal of Personality and Social Psychology, 72(4), 907–917. https://doi.org/10.1037/0022-3514.72.4.907
Costa, P. T., Jr., & McCrae, R. R. (1987). Neuroticism, somatic complaints, and disease: Is the bark worse than the bite? Journal of Personality, 55(2), 299–316. https://doi.org/10.1111/j.1467-6494.1987.tb00438.x
De Gucht, V. (2003). Stability of neuroticism and alexithymia in somatization. Comprehensive Psychiatry, 44(6), 466–471. https://doi.org/10.1016/S0010-440X(03)00143-3
Denovan, A., Dagnall, N., & Lofthouse, G. (2019). Neuroticism and somatic complaints: Concomitant effects of rumination and worry. Behavioural and Cognitive Psychotherapy, 47(4), 431–445. https://doi.org/10.1017/S1352465818000619
Gierk, B., Kohlmann, S., Kroenke, K., Spangenberg, L., Zenger, M., Brähler, E., & Löwe, B. (2014). The Somatic Symptom Scale–8 (SSS-8): A brief measure of somatic symptom burden. JAMA Internal Medicine, 174(3), 399–407. https://doi.org/10.1001/jamainternmed.2013.12179
Howren, M. B., & Suls, J. (2011). The symptom perception hypothesis revised: Depression and anxiety play different roles in concurrent and retrospective physical symptom reporting. Journal of Personality and Social Psychology, 100(1), 182–195. https://doi.org/10.1037/a0021715
Kelly, D. P., Weigard, A., & Beltz, A. M. (2020). How are you doing? The person-specificity of daily links between neuroticism and physical health. Journal of Psychosomatic Research, 137, 110194. https://doi.org/10.1016/j.jpsychores.2020.110194
Lahey, B. B. (2009). Public health significance of neuroticism. American Psychologist, 64(4), 241–256. https://doi.org/10.1037/a0015309
Lamm, T. T., von Schrottenberg, V., Rauch, A., Bach, B., Pedersen, H. F., Rask, M. T., Ørnbøl, E., Wellnitz, K. B., & Frostholm, L. (2025). Five-factor personality traits and functional somatic disorder: A systematic review and meta-analysis. Clinical Psychology Review, 115, 102529. https://doi.org/10.1016/j.cpr.2024.102529
Neeleman, J., Bijl, R., & Ormel, J. (2004). Neuroticism, a central link between somatic and psychiatric morbidity: Path analysis of prospective data. Psychological Medicine, 34(3), 521–531. https://doi.org/10.1017/S0033291703001193
Ormel, J., Jeronimus, B. F., Kotov, R., Riese, H., Bos, E. H., Hankin, B., Rosmalen, J. G. M., & Oldehinkel, A. J. (2013). Neuroticism and common mental disorders: Meaning and utility of a complex relationship. Clinical Psychology Review, 33(5), 686–697. https://doi.org/10.1016/j.cpr.2013.04.003
Petersen, M. W., Carstensen, T. B. W., Wellnitz, K. B., Ørnbøl, E., Frostholm, L., Dantoft, T. M., Jørgensen, T., Eplov, L. F., & Fink, P. (2024). Neuroticism, perceived stress, adverse life events and self-efficacy as predictors of the development of functional somatic disorders: Longitudinal population-based study (DanFunD). BJPsych Open, 10(1), e34. https://doi.org/10.1192/bjo.2023.644
Rosmalen, J. G. M., Neeleman, J., Gans, R. O. B., & de Jonge, P. (2007). The association between neuroticism and self-reported common somatic symptoms in a population cohort. Journal of Psychosomatic Research, 62(3), 305–311. https://doi.org/10.1016/j.jpsychores.2006.10.014
Soto, C. J., & John, O. P. (2017). The next Big Five Inventory (BFI-2): Developing and assessing a hierarchical model with 15 facets to enhance bandwidth, fidelity, and predictive power. Journal of Personality and Social Psychology, 113(1), 117–143. https://doi.org/10.1037/pspp0000096
Strickhouser, J. E., Zell, E., & Krizan, Z. (2017). Does personality predict health and well-being? A metasynthesis. Health Psychology, 36(8), 797–810. https://doi.org/10.1037/hea0000475
Watson, D., & Pennebaker, J. W. (1989). Health complaints, stress, and distress: Exploring the central role of negative affectivity. Psychological Review, 96(2), 234–254. https://doi.org/10.1037/0033-295X.96.2.234
Yoneda, T., Lozinski, T., Turiano, N., Booth, T., Graham, E. K., Mroczek, D., & Muniz Terrera, G. (2023). The Big Five personality traits and allostatic load in middle to older adulthood: A systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews, 148, 105145. https://doi.org/10.1016/j.neubiorev.2023.105145